601 related articles for article (PubMed ID: 34715867)
1. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
[TBL] [Abstract][Full Text] [Related]
2. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
[TBL] [Abstract][Full Text] [Related]
4. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
[TBL] [Abstract][Full Text] [Related]
5. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
6. Integrated Nanorod-Mediated PD-L1 Downregulation in Combination with Oxidative-Stress Immunogene Therapy against Cancer.
Wu S; Zhang J; Pan J; Bai S; Wang Z; Chen Y; Xu D; An Y; Liu C; Chu C; Dai Q; Jiang L; Lu Z; Liu G
Adv Healthc Mater; 2023 Jul; 12(17):e2300110. PubMed ID: 36773310
[TBL] [Abstract][Full Text] [Related]
7. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer.
Nesbitt H; Logan K; Thomas K; Callan B; Gao J; McKaig T; Taylor M; Love M; Stride E; McHale AP; Callan JF
Cancer Lett; 2021 Oct; 517():88-95. PubMed ID: 34119606
[TBL] [Abstract][Full Text] [Related]
8. TiSe
Chen L; Xue W; Cao J; Zhang S; Zeng Y; Ma L; Qian X; Wen Q; Hong Y; Shi Z; Xu Y
J Nanobiotechnology; 2022 Oct; 20(1):453. PubMed ID: 36243711
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis.
Chen S; Ma T; Wang J; Liang S; Liao H; Tan W; Chen M; Zhou X; Xu Y; Wang L; Niu C
Biomaterials; 2024 Mar; 305():122456. PubMed ID: 38184961
[TBL] [Abstract][Full Text] [Related]
10. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation.
Huang T; Wu W; Wu J; Tan Y; Zhang M; Long H; Guo H; Zhang X; Zhou W; Zhang Q; Xie X; Xu M; Zhang C
Front Immunol; 2023; 14():1124152. PubMed ID: 37051250
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
[No Abstract] [Full Text] [Related]
12. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.
Huang J; Xiao Z; An Y; Han S; Wu W; Wang Y; Guo Y; Shuai X
Biomaterials; 2021 Feb; 269():120636. PubMed ID: 33453632
[TBL] [Abstract][Full Text] [Related]
13. Homology and Immune Checkpoint Dual-Targeted Sonocatalytic Nanoagents for Enhancing Sonodynamic Tumor Therapy.
Wei X; Feng Z; Huang J; Xiang X; Du F; He C; Zhou M; Ma L; Cheng C; Qiu L
ACS Appl Mater Interfaces; 2021 Jul; 13(28):32810-32822. PubMed ID: 34232622
[TBL] [Abstract][Full Text] [Related]
14. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
15. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
16. Tumor-targeting biomimetic sonosensitizer-conjugated iron oxide nanocatalysts for combinational chemodynamic-sonodynamic therapy of colorectal cancer.
Chen X; Cheng D; Ding M; Yu N; Liu J; Li J; Lin L
J Mater Chem B; 2022 Jun; 10(24):4595-4604. PubMed ID: 35642510
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
[No Abstract] [Full Text] [Related]
18. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide-based sonodynamic therapy induces immunogenic cell death in glioma.
Zhou Y; Jiao J; Yang R; Wen B; Wu Q; Xu L; Tong X; Yan H
Clin Immunol; 2023 Nov; 256():109772. PubMed ID: 37716612
[TBL] [Abstract][Full Text] [Related]
20. Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma.
Ma Y; Li J; Zhao Y; Hu B; Liu Y; Liu C
Eur J Pharm Biopharm; 2022 Dec; 181():36-48. PubMed ID: 36307001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
